G+FLASLIFE SCIENCES
G+FLAS Life sciences has been developing
CRISPR/Cas foundation technologies as well as
innovative applications for better human health,
including gene therapy drugs, biopharmaceuticals,
and novel seeds with desired traits.
G+FLASLIFE SCIENCES
G+FLAS Life sciences has been developing
CRISPR/Cas foundation technologies as well as
innovative applications for better human health,
including gene therapy drugs, biopharmaceuticals,
and novel seeds with desired traits.
G+FLASLIFE SCIENCES
G+FLAS Life sciences has been developing
CRISPR/Cas foundation technologies as well as
innovative applications for better human health,
including gene therapy drugs, biopharmaceuticals,
and novel seeds with desired traits.
CRISPRGenome Editing Tech
An artificial CRISPR ribonucleoprotein (RNP) binds and cleaves
target DNA, which has the complementary sequence of sgRNA
PLANT NON-GMO CRISPRGenome Editing in Plants
An artificial CRISPR RNP binds
and cleaves target DNA in plants
BIOLOGICALSPlant-Based Biopharmaceutical Production
Biologicals, which produces massively through microbiome and
culture cells by recombinant DNA technology
Contact Us
-
123, Uiryodanji-gil, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea
- TEL043-236-2201